Cargando…

Functional Tissue Engineering: A Prevascularized Cardiac Muscle Construct for Validating Human Mesenchymal Stem Cells Engraftment Potential In Vitro

The influence of somatic stem cells in the stimulation of mammalian cardiac muscle regeneration is still in its early stages, and so far, it has been difficult to determine the efficacy of the procedures that have been employed. The outstanding question remains whether stem cells derived from the bo...

Descripción completa

Detalles Bibliográficos
Autores principales: Valarmathi, Mani T., Fuseler, John W., Potts, Jay D., Davis, Jeffrey M., Price, Robert L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5770135/
https://www.ncbi.nlm.nih.gov/pubmed/28457188
http://dx.doi.org/10.1089/ten.tea.2016.0539
_version_ 1783293026991341568
author Valarmathi, Mani T.
Fuseler, John W.
Potts, Jay D.
Davis, Jeffrey M.
Price, Robert L.
author_facet Valarmathi, Mani T.
Fuseler, John W.
Potts, Jay D.
Davis, Jeffrey M.
Price, Robert L.
author_sort Valarmathi, Mani T.
collection PubMed
description The influence of somatic stem cells in the stimulation of mammalian cardiac muscle regeneration is still in its early stages, and so far, it has been difficult to determine the efficacy of the procedures that have been employed. The outstanding question remains whether stem cells derived from the bone marrow or some other location within or outside of the heart can populate a region of myocardial damage and transform into tissue-specific differentiated progenies, and also exhibit functional synchronization. Consequently, this necessitates the development of an appropriate in vitro three-dimensional (3D) model of cardiomyogenesis and prompts the development of a 3D cardiac muscle construct for tissue engineering purposes, especially using the somatic stem cell, human mesenchymal stem cells (hMSCs). To this end, we have created an in vitro 3D functional prevascularized cardiac muscle construct using embryonic cardiac myocytes (eCMs) and hMSCs. First, to generate the prevascularized scaffold, human cardiac microvascular endothelial cells (hCMVECs) and hMSCs were cocultured onto a 3D collagen cell carrier (CCC) for 7 days under vasculogenic culture conditions; hCMVECs/hMSCs underwent maturation, differentiation, and morphogenesis characteristic of microvessels, and formed dense vascular networks. Next, the eCMs and hMSCs were cocultured onto this generated prevascularized CCCs for further 7 or 14 days in myogenic culture conditions. Finally, the vascular and cardiac phenotypic inductions were characterized at the morphological, immunological, biochemical, molecular, and functional levels. Expression and functional analyses of the differentiated progenies revealed neo-cardiomyogenesis and neo-vasculogenesis. In this milieu, for instance, not only were hMSCs able to couple electromechanically with developing eCMs but were also able to contribute to the developing vasculature as mural cells, respectively. Hence, our unique 3D coculture system provides us a reproducible and quintessential in vitro 3D model of cardiomyogenesis and a functioning prevascularized 3D cardiac graft that can be utilized for personalized medicine.
format Online
Article
Text
id pubmed-5770135
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Mary Ann Liebert, Inc.
record_format MEDLINE/PubMed
spelling pubmed-57701352018-01-17 Functional Tissue Engineering: A Prevascularized Cardiac Muscle Construct for Validating Human Mesenchymal Stem Cells Engraftment Potential In Vitro Valarmathi, Mani T. Fuseler, John W. Potts, Jay D. Davis, Jeffrey M. Price, Robert L. Tissue Eng Part A Original Articles The influence of somatic stem cells in the stimulation of mammalian cardiac muscle regeneration is still in its early stages, and so far, it has been difficult to determine the efficacy of the procedures that have been employed. The outstanding question remains whether stem cells derived from the bone marrow or some other location within or outside of the heart can populate a region of myocardial damage and transform into tissue-specific differentiated progenies, and also exhibit functional synchronization. Consequently, this necessitates the development of an appropriate in vitro three-dimensional (3D) model of cardiomyogenesis and prompts the development of a 3D cardiac muscle construct for tissue engineering purposes, especially using the somatic stem cell, human mesenchymal stem cells (hMSCs). To this end, we have created an in vitro 3D functional prevascularized cardiac muscle construct using embryonic cardiac myocytes (eCMs) and hMSCs. First, to generate the prevascularized scaffold, human cardiac microvascular endothelial cells (hCMVECs) and hMSCs were cocultured onto a 3D collagen cell carrier (CCC) for 7 days under vasculogenic culture conditions; hCMVECs/hMSCs underwent maturation, differentiation, and morphogenesis characteristic of microvessels, and formed dense vascular networks. Next, the eCMs and hMSCs were cocultured onto this generated prevascularized CCCs for further 7 or 14 days in myogenic culture conditions. Finally, the vascular and cardiac phenotypic inductions were characterized at the morphological, immunological, biochemical, molecular, and functional levels. Expression and functional analyses of the differentiated progenies revealed neo-cardiomyogenesis and neo-vasculogenesis. In this milieu, for instance, not only were hMSCs able to couple electromechanically with developing eCMs but were also able to contribute to the developing vasculature as mural cells, respectively. Hence, our unique 3D coculture system provides us a reproducible and quintessential in vitro 3D model of cardiomyogenesis and a functioning prevascularized 3D cardiac graft that can be utilized for personalized medicine. Mary Ann Liebert, Inc. 2018-01-01 2018-01-01 /pmc/articles/PMC5770135/ /pubmed/28457188 http://dx.doi.org/10.1089/ten.tea.2016.0539 Text en © Mani T. Valarmathi et al. 2018; Published by Mary Ann Liebert, Inc. This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Valarmathi, Mani T.
Fuseler, John W.
Potts, Jay D.
Davis, Jeffrey M.
Price, Robert L.
Functional Tissue Engineering: A Prevascularized Cardiac Muscle Construct for Validating Human Mesenchymal Stem Cells Engraftment Potential In Vitro
title Functional Tissue Engineering: A Prevascularized Cardiac Muscle Construct for Validating Human Mesenchymal Stem Cells Engraftment Potential In Vitro
title_full Functional Tissue Engineering: A Prevascularized Cardiac Muscle Construct for Validating Human Mesenchymal Stem Cells Engraftment Potential In Vitro
title_fullStr Functional Tissue Engineering: A Prevascularized Cardiac Muscle Construct for Validating Human Mesenchymal Stem Cells Engraftment Potential In Vitro
title_full_unstemmed Functional Tissue Engineering: A Prevascularized Cardiac Muscle Construct for Validating Human Mesenchymal Stem Cells Engraftment Potential In Vitro
title_short Functional Tissue Engineering: A Prevascularized Cardiac Muscle Construct for Validating Human Mesenchymal Stem Cells Engraftment Potential In Vitro
title_sort functional tissue engineering: a prevascularized cardiac muscle construct for validating human mesenchymal stem cells engraftment potential in vitro
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5770135/
https://www.ncbi.nlm.nih.gov/pubmed/28457188
http://dx.doi.org/10.1089/ten.tea.2016.0539
work_keys_str_mv AT valarmathimanit functionaltissueengineeringaprevascularizedcardiacmuscleconstructforvalidatinghumanmesenchymalstemcellsengraftmentpotentialinvitro
AT fuselerjohnw functionaltissueengineeringaprevascularizedcardiacmuscleconstructforvalidatinghumanmesenchymalstemcellsengraftmentpotentialinvitro
AT pottsjayd functionaltissueengineeringaprevascularizedcardiacmuscleconstructforvalidatinghumanmesenchymalstemcellsengraftmentpotentialinvitro
AT davisjeffreym functionaltissueengineeringaprevascularizedcardiacmuscleconstructforvalidatinghumanmesenchymalstemcellsengraftmentpotentialinvitro
AT pricerobertl functionaltissueengineeringaprevascularizedcardiacmuscleconstructforvalidatinghumanmesenchymalstemcellsengraftmentpotentialinvitro